Home
About
Overview
Sharing Data
ORCID
Help
History (14)
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
Editorial Comment.
8q24 genetic variation and comprehensive haplotypes altering familial risk of prostate cancer.
Patterns of initial transitional cell recurrence in patients after cystectomy.
Advances in the management of castration resistant prostate cancer.
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Advances in the management of castration resistant prostate cancer.
Advances in the management of castration resistant prostate cancer. BMJ. 2016 Oct 17; 355:i4405.
View in:
PubMed
subject areas
Aged
Androstenes
Androstenols
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Benzamides
Disease Management
Humans
Immunotherapy
Male
Middle Aged
Neoplasm Invasiveness
Neoplasm Staging
Nitriles
Phenylthiohydantoin
Prognosis
Prostatic Neoplasms, Castration-Resistant
Randomized Controlled Trials as Topic
Risk Assessment
Survival Analysis
Taxoids
Treatment Outcome
authors with profiles
Michael S Cookson